Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
2.235
-0.245 (-9.88%)
At close: Apr 3, 2025, 4:00 PM
2.292
+0.057 (2.53%)
Pre-market: Apr 4, 2025, 4:05 AM EDT
Absci Revenue
In the year 2024, Absci had annual revenue of $4.53M, down -20.71%. Absci had revenue of $665.00K in the quarter ending December 31, 2024, with 96.75% growth.
Revenue (ttm)
$4.53M
Revenue Growth
-20.71%
P/S Ratio
54.34
Revenue / Employee
$28,879
Employees
157
Market Cap
284.59M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ABSI News
- 13 hours ago - Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market - Seeking Alpha
- 8 days ago - Absci to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 15 days ago - Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
- 16 days ago - Absci Corporation (ABSI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results - GlobeNewsWire
- 4 weeks ago - Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025 - GlobeNewsWire
- 4 weeks ago - Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Absci to Participate in the KeyBanc Capital Markets Healthcare Forum - GlobeNewsWire